Isolation of tumor antigen-specific single-chain variable fragments using a chimeric antigen receptor bicistronic retroviral vector in a mammalian screening protocol

Human Gene Therapy Methods

Volumn 24, Issue 6, 2013, Pages 381-391

  Lipowska Bhalla, Grazyna ^a   Gilham, David E ^a   Hawkins, Robert E ^a   Rothwell, Dominic G ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CD69 ANTIGEN; CHIMERIC ANTIGEN RECEPTOR; LYMPHOCYTE ANTIGEN RECEPTOR; RETROVIRUS VECTOR; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN SPECIFICITY; ARTICLE; CELL DENSITY; DNA LIBRARY; EMBRYO; GENE EXPRESSION; HUMAN; HUMAN CELL; MAMMAL CELL; MOLECULAR CLONING; PHAGE DISPLAY; PRIORITY JOURNAL; T LYMPHOCYTE; UPREGULATION; VIRAL GENE DELIVERY SYSTEM;

FLOW CYTOMETRY; GENETIC VECTORS; HEK293 CELLS; HUMANS; IMMUNOASSAY; JURKAT CELLS; PEPTIDE LIBRARY; RECEPTORS, ANTIGEN; RETROVIRIDAE; SINGLE-CHAIN ANTIBODIES;

EID: 84890365422     PISSN: 19466536     EISSN: 19466544     Source Type: Journal    
DOI: 10.1089/hgtb.2013.068     Document Type: Article

References (42)

1. Alonso-Camino, V., Sanchez-Martin, D., Compte, M., et al. (2009). Lymphocyte display: A novel antibody selection platform based on T cell activation. PLoS One 4, e7174
2. Boder, E.T., and Wittrup, K.D. (1997). Yeast surface display for screening combinatorial polypeptide libraries. Nat. Biotechnol. 15, 553-557
3. Brentjens, R.J., Santos, E., Nikhamin, Y., et al. (2007). Genetically targeted T cells eradicate systemic acute lymphoblastic leukemia xenografts. Clin. Cancer Res. 13, 5426-5435
4. Brentjens, R.J., Riviere, I., Park, J.H., et al. (2011). Safety and persistence of adoptively transferred autologous CD19-Targeted T cells in patients with relapsed or chemotherapy refractory B-cell leukemias. Blood 118, 4817-4828
5. Carpenito, C., Milone, M.C., Hassan, R., et al. (2009). Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains. Proc. Natl. Acad. Sci. USA 106, 3360-3365
6. Casey, J.L., Keep, P.A., Chester, K.A., et al. (1995). Purification of bacterially expressed single chain Fv antibodies for clinical applications using metal chelate chromatography. J. Immunol. Methods 179, 105-116
7. Cheadle, E.J., Gilham, D.E., and Hawkins, R.E. (2008). The combination of cyclophosphamide and human T cells genetically engineered to target CD19 can eradicate established B-cell lymphoma. Br. J. Haematol. 142, 65-68
8. Chester, K.A., Begent, R.H., Robson, L., et al. (1994). Phage libraries for generation of clinically useful antibodies. Lancet 343, 455-456
9. Engels, B., Cam, H., Schuler, T., et al. (2003). Retroviral vectors for high-level transgene expression in T lymphocytes. Hum. Gene Ther. 14, 1155-1168
10. Fehse, B., Richters, A., Putimtseva-Scharf, K., et al. (2000). CD34 splice variant: An attractive marker for selection of genemodified cells. Mol. Ther. 1, 448-456
11. Feldhaus, M.J., Siegel, R.W., Opresko, L.K., et al. (2003). Flowcytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library. Nat. Biotechnol. 21, 163-170
12. Finer, M.H., Dull, T.J., Qin, L., et al. (1994). kat: A high-efficiency retroviral transduction system for primary human T lymphocytes. Blood 83, 43-50
13. Gao, C., Mao, S., Kaufmann, G., et al. (2002). A method for the generation of combinatorial antibody libraries using pIX phage display. Proc. Natl. Acad. Sci. USA 99, 12612-12616
14. Gross, G., Waks, T., and Eshhar, Z. (1989). Expression of immunoglobulin-T-cell receptor chimeric molecules as functional receptors with antibody-Type specificity. Proc. Natl. Acad. Sci. USA 86, 10024-10028
15. Hanes, J., and Pluckthun, A. (1997). In vitro selection and evolution of functional proteins by using ribosome display. Proc. Natl. Acad. Sci. USA 94, 4937-4942
16. Haynes, N.M., Trapani, J.A., Teng, M.W., et al. (2002). Singlechain antigen recognition receptors that costimulate potent rejection of established experimental tumors. Blood 100, 3155-3163
17. He, M., and Taussig, M.J. (1997). Antibody-ribosome-mRNA (ARM) complexes as efficient selection particles for in vitro display and evolution of antibody combining sites. Nucleic Acids Res. 25, 5132-5134
18. Ho, M., Nagata, S., and Pastan, I. (2006). Isolation of anti-CD22 Fv with high affinity by Fv display on human cells. Proc. Natl. Acad. Sci. USA 103, 9637-9642
19. Hombach, A., Sent, D., Schneider, C., et al. (2001). T-cell activation by recombinant receptors: CD28 costimulation is required for interleukin 2 secretion and receptor-mediated T-cell proliferation but does not affect receptor-mediated target cell lysis. Cancer Res. 61, 1976-1982
20. Hoogenboom, H.R. (2005). Selecting and screening recombinant antibody libraries. Nat. Biotechnol. 23, 1105-1116
21. Kalos, M. (2012). Muscle CARs and TcRs: Turbo-charged technologies for the (T cell) masses. Cancer Immunol. Immunother. 61, 127-135
22. Kalos, M., Levine, B.L., Porter, D.L., et al. (2011). T cells with chimeric antigen receptors have potent antitumor effects and can establish memory in patients with advanced leukemia. Sci. Transl. Med. 3, 95ra73
23. Klump, H., Schiedlmeier, B., Vogt, B., et al. (2001). Retroviral vector-mediated expression of HoxB4 in hematopoietic cells using a novel coexpression strategy. Gene Ther. 8, 811-817
24. Kochenderfer, J.N., Wilson, W.H., Janik, J.E., et al. (2010). Eradication of B-lineage cells and regression of lymphoma in a patient treated with autologous T cells genetically engineered to recognize CD19. Blood 116, 4099-4102
25. Kochenderfer, J.N., Dudley, M.E., Feldman, S.A., et al. (2012). Bcell depletion and remissions of malignancy along with cytokine-Associated toxicity in a clinical trial of anti-CD19 chimeric-Antigen-receptor-Transduced T cells. Blood 119, 2709-2720
26. Lipowska-Bhalla, G., Gilham, D.E., Hawkins, R.E., and Rothwell, D.G. (2012). Targeted immunotherapy of cancer with CAR T cells: Achievements and challenges. Cancer Immunol. Immunother. 61, 953-962
27. Loskog, A., Giandomenico, V., Rossig, C., et al. (2006). Addition of the CD28 signaling domain to chimeric T-cell receptors enhances chimeric T-cell resistance to T regulatory cells. Leukemia 20, 1819-1828
28. Louis, C.U., Savoldo, B., Dotti, G., et al. (2011). Antitumor activity and long-Term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma. Blood 118, 6050-6056
29. Mamalaki, A., Gritzapis, A.D., Kretsovali, A., et al. (2003). In vitro and in vivo antitumor activity of a mouse CTL hybridoma expressing chimeric receptors bearing the single chain Fv from HER-2/neu-specific antibody and the gamma-chain from Fc(epsilon) RI. Cancer Immunol. Immunother. 52, 513-522
30. Milone, M.C., Fish, J.D., Carpenito, C., et al. (2009). Chimeric receptors containing CD137 signal transduction domains mediate enhanced survival of T cells and increased antileukemic efficacy in vivo. Mol. Ther. 17, 1453-1464
31. Park, J.R., Digiusto, D.L., Slovak, M., et al. (2007). Adoptive transfer of chimeric antigen receptor re-directed cytolytic T lymphocyte clones in patients with neuroblastoma. Mol. Ther. 15, 825-833
32. Pinthus, J.H., Waks, T., Kaufman-Francis, K., et al. (2003). Immuno-gene therapy of established prostate tumors using chimeric receptor-redirected human lymphocytes. Cancer Res. 63, 2470-2476
33. Porter, D.L., Levine, B.L., Kalos, M., et al. (2011). Chimeric antigen receptor-modified T cells in chronic lymphoid leukemia. N. Engl. J. Med. 365, 725-733
34. Pule, M.A., Straathof, K.C., Dotti, G., et al. (2005). A chimeric T cell antigen receptor that augments cytokine release and supports clonal expansion of primary human T cells. Mol. Ther. 12, 933-941
35. Pule, M.A., Savoldo, B., Myers, G.D., et al. (2008). Virus-specific T cells engineered to coexpress tumor-specific receptors: Persistence and antitumor activity in individuals with neuroblastoma. Nat. Med. 14, 1264-1270
36. Restifo, N.P., Dudley, M.E., and Rosenberg, S.A. (2012). Adoptive immunotherapy for cancer: Harnessing the T cell response. Nat. Rev. Immunol. 12, 269-281
37. Smith, G.P. (1985). Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface. Science 228, 1315-1317
38. Teng, M.W., Kershaw, M.H., Moeller, M., et al. (2004). Immunotherapy of cancer using systemically delivered gene-modified human T lymphocytes. Hum. Gene Ther. 15, 699-708
39. Till, B.G., Jensen, M.C., Wang, J., et al. (2008). Adoptive immunotherapy for indolent non-Hodgkin lymphoma and mantle cell lymphoma using genetically modified autologous CD20-specific T cells. Blood 112, 2261-2271
40. van den Beucken, T., Pieters, H., Steukers, M., et al. (2003). Affinity maturation of Fab antibody fragments by fluorescentactivated cell sorting of yeast-displayed libraries. FEBS Lett. 546, 288-294
41. Wilson, D.S., Keefe, A.D., and Szostak, J.W. (2001). The use of mRNA display to select high-Affinity protein-binding peptides. Proc. Natl. Acad. Sci. USA 98, 3750-3755
42. Zhao, Y., Wang, Q.J., Yang, S., et al. (2009). A herceptin-based chimeric antigen receptor with modified signaling domains leads to enhanced survival of transduced T lymphocytes and antitumor activity. J. Immunol. 183, 5563-5574